
Chandra Bhagat Pharma Share Price
₹65.00 -2 (-2.99%)
23 Feb, 2025 10:43
Start SIP in
CBPL
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month -4.41%
- Over 3 Month -5.8%
- Over 6 Month -14.47%
- Over 1 Year -51.04%
Smart Investing Starts Here Start SIP with Chandra Bhagat Pharma for Steady Growth!
Chandra Bhagat Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Chandra Bhagat Pharma Financials
Chandra Bhagat Pharma Technicals
EMA & SMA
Current Price
₹65.00
-2
(-2.99%)

-
- Bearish Moving Average 11
-
- Bullish Moving Average 5
- 20 Day
- ₹65.53
- 50 Day
- ₹68.08
- 100 Day
- ₹74.46
- 200 Day
- ₹85.08
Resistance and Support
65
- R3 71.00
- R2 69.00
- R1 67.00
- S1 63.00
- S2 61.00
- S3 59.00
Chandra Bhagat Pharma Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-13 | Half Yearly Results | |
2024-05-30 | Audited Results | |
2023-11-09 | Half Yearly Results | |
2023-05-22 | Audited Results | |
2022-11-14 | Half Yearly Results |
Chandra Bhagat Pharma F&O
About Chandra Bhagat Pharma
- NSE Symbol
- CBPL
- BSE Symbol
- 542934
- ISIN
- INE07QQ01016
Similar Stocks to Chandra Bhagat Pharma
Chandra Bhagat Pharma FAQs
Chandra Bhagat Pharma share price is ₹65 As on 23 February, 2025 | 10:29
The Market Cap of Chandra Bhagat Pharma is ₹49 Cr As on 23 February, 2025 | 10:29
The P/E ratio of Chandra Bhagat Pharma is 32 As on 23 February, 2025 | 10:29
The PB ratio of Chandra Bhagat Pharma is 1.7 As on 23 February, 2025 | 10:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.